Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - ct945 - general laboratoryware ivds - laboratoryware such as general reagents, consumables, laboratory products and biological stains, that are intended to be used specifically as ivds in the testing of clinical specimens within any discipline of a pathology laboratory.

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - ct879 - haematology calibrator/control ivds - for in vitro diagnostic use in testing to establish known points of reference and/or verify the performance of haematological assays.

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - ct878 - haematology full blood count ivds - for in vitro diagnostic use in the quantitative and/or qualitative haematological determination of measured and/or calculated whole blood cell parameters.

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - ct806 - haemoximetry and blood gas ivds - for the determination of po2, pco2, ph, thb, and haemoglobin derivatives in arterial, venous, and capillary whole blood samples.

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - ct704 - hepatitis b virus ivds - for in vitro diagnostic use in testing clinical specimens to provide information about infection with hepatitis b virus (hbv). the ivd is intended to be used in conjunction with clinical presentation and other laboratory markers to aid in the management of hbv-infected individuals undergoing antiviral therapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - ct705 - hepatitis c virus ivds - these are ivds that are intended to be used in testing to provide information about infection with or exposure to hepatitis c virus. these assays are intended to be used in conjunction with clinical presentation and other laboratory markers of disease status to aid in the management of hcv infected patients. they are not intended to be used as diagnostic assays to confirm the presence of hcv infection or as donor screening assays for hcv.

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - ct866 - immunosuppressant therapeutic drug monitoring ivds - for in vitro diagnostic use in therapeutic monitoring of drugs targeting the immune system in clinical specimens.

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - 37654 - mri system, full-body, superconducting magnet - these magnetic resonance diagnostic devices are designed to produce transverse, sagittal, coronal and oblique cross sectional images, spectroscopic images and/or spectra that display the internal structure and/or function of the head, body, or extremities.

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - ct889 - multiple clinical chemistry constituent ivds - for in vitro diagnostic use in the quantitative and/or qualitative determination of multiple analytes from more than one clinical chemistry speciality, in a clinical specimen.

Australia - English - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - ct889 - multiple clinical chemistry constituent ivds - for in vitro diagnostic use in the quantitative and/or qualitative determination of multiple analytes from more than one clinical chemistry speciality, in a clinical specimen.